NO923739D0 - Kontrastmidler - Google Patents

Kontrastmidler

Info

Publication number
NO923739D0
NO923739D0 NO923739A NO923739A NO923739D0 NO 923739 D0 NO923739 D0 NO 923739D0 NO 923739 A NO923739 A NO 923739A NO 923739 A NO923739 A NO 923739A NO 923739 D0 NO923739 D0 NO 923739D0
Authority
NO
Norway
Prior art keywords
contrast agents
agents
contrast
Prior art date
Application number
NO923739A
Other languages
English (en)
Other versions
NO923739L (no
Inventor
Arne Berg
Torsten Almen
Klaus Dieter Krautwurst
Sook-Hui Kim
Paal Rongved
Jo Klaveness
Harald Dugstad
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB909006977A priority Critical patent/GB9006977D0/en
Priority to PCT/EP1991/000587 priority patent/WO1991014460A1/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO923739D0 publication Critical patent/NO923739D0/no
Publication of NO923739L publication Critical patent/NO923739L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F11/00Compounds containing elements of Groups 6 or 16 of the Periodic System
    • C07F11/005Compounds containing elements of Groups 6 or 16 of the Periodic System compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K2123/00Preparations for testing in vivo
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/836Chelate
NO92923739A 1990-03-28 1992-09-25 Kontrastmidler NO923739L (no)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB909006977A GB9006977D0 (en) 1990-03-28 1990-03-28 Compositions
PCT/EP1991/000587 WO1991014460A1 (en) 1990-03-28 1991-03-27 Contrast media

Publications (2)

Publication Number Publication Date
NO923739D0 true NO923739D0 (no) 1992-09-25
NO923739L NO923739L (no) 1992-11-06

Family

ID=10673438

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92923739A NO923739L (no) 1990-03-28 1992-09-25 Kontrastmidler

Country Status (18)

Country Link
US (2) US5458869A (no)
EP (2) EP0645146A1 (no)
JP (1) JPH06507147A (no)
AT (1) AT142508T (no)
AU (1) AU645796B2 (no)
CA (1) CA2079212A1 (no)
DE (1) DE69122092T2 (no)
DK (1) DK0521977T3 (no)
ES (1) ES2091323T3 (no)
FI (1) FI924297A0 (no)
GB (1) GB9006977D0 (no)
HK (1) HK219596A (no)
HU (2) HUT69168A (no)
LT (1) LT3535B (no)
LV (1) LV10056B (no)
NO (1) NO923739L (no)
SG (1) SG43931A1 (no)
WO (1) WO1991014460A1 (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017215A1 (en) 1990-03-28 1992-10-15 Nycomed Salutar, Inc. Contrast media
AU660013B2 (en) * 1991-03-27 1995-06-08 Nycomed Salutar, Inc. Contrast media
GB9006977D0 (en) * 1990-03-28 1990-05-23 Nycomed As Compositions
US5330742A (en) * 1991-08-05 1994-07-19 Mallinckrodt Medical, Inc. Methods and compositions for magnetic resonance imaging
EP0597865B1 (en) * 1991-08-05 2001-07-25 Mallinckrodt Inc. Heavy metal clusters for use as imaging agents
US5364953A (en) * 1992-11-05 1994-11-15 Mallinckrodt Medical, Inc. High relaxivity, paramagnetic, metal clusters for magnetic resonance imaging
GB9407812D0 (en) * 1994-04-20 1994-06-15 Nycomed Salutar Inc Compounds
GB9420390D0 (en) * 1994-10-10 1994-11-23 Nycomed Salutar Inc Liposomal agents
US5717121A (en) * 1995-06-07 1998-02-10 Nycomed Salutar, Inc. Preparation and use of contrast agents
GB9601340D0 (en) * 1996-01-23 1996-03-27 Nycomed Salutar Inc Contrast media
WO1997030459A1 (en) * 1996-02-14 1997-08-21 Philips Electronics N.V. X-ray examination apparatus with x-ray filter
US5804161A (en) * 1996-05-14 1998-09-08 Nycomed Salutar Inc. Contrast agents
US6537520B1 (en) 1998-03-31 2003-03-25 Bristol-Myers Squibb Pharma Company Pharmaceuticals for the imaging of angiogenic disorders
US6524553B2 (en) 1998-03-31 2003-02-25 Bristol-Myers Squibb Pharma Company Quinolone vitronectin receptor antagonist pharmaceuticals
US6548663B1 (en) 1998-03-31 2003-04-15 Bristol-Myers Squibb Pharma Company Benzodiazepine vitronectin receptor antagonist pharmaceuticals
TR200101757T2 (tr) 1998-12-18 2001-12-21 Dupont Pharmaceuticais Company Vitronektin reseptör antagonisti farmasötikler
US6794518B1 (en) 1998-12-18 2004-09-21 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
US6511649B1 (en) 1998-12-18 2003-01-28 Thomas D. Harris Vitronectin receptor antagonist pharmaceuticals
NZ511677A (en) 1998-12-18 2003-10-31 Du Pont Pharm Co Vitronectin receptor antagonist pharmaceuticals
US6569402B1 (en) 1998-12-18 2003-05-27 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
US6596259B1 (en) * 1998-12-22 2003-07-22 University Of Puerto Rico Metal based cubane structure contained in an octanuclear complex stable over several oxidation states and a method of producing the same
US7807137B1 (en) 1998-12-22 2010-10-05 University Of Puerto Rico Iron-based contrast agent
US6656448B1 (en) 2000-02-15 2003-12-02 Bristol-Myers Squibb Pharma Company Matrix metalloproteinase inhibitors
WO2001087354A2 (en) 2000-05-17 2001-11-22 Bristol-Myers Squibb Pharma Company Use of small molecule radioligands for diagnostic imaging
NZ516746A (en) 2000-06-01 2004-02-27 Bristol Myers Squibb Pharma Lactams substituted by cyclic succinates as inhibitors of A-beta protein production
HU0400758A3 (en) 2000-11-03 2005-02-28 Bristol Myers Squibb Pharma Co Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
US7928278B2 (en) * 2001-06-12 2011-04-19 University Of Florida Research Foundation, Inc. Method and apparatus for producing near-infrared radiation
US6838074B2 (en) 2001-08-08 2005-01-04 Bristol-Myers Squibb Company Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
CA2452478A1 (en) 2001-08-08 2003-02-20 Bristol-Myers Squibb Pharma Company Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
US20050106100A1 (en) * 2003-09-03 2005-05-19 Harris Thomas D. Compounds containing matrix metalloproteinase substrates and methods of their use
US7344702B2 (en) 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
US7485283B2 (en) 2004-04-28 2009-02-03 Lantheus Medical Imaging Contrast agents for myocardial perfusion imaging
JP4322781B2 (ja) * 2004-11-08 2009-09-02 富士フイルム株式会社 撮像装置
JP2009500410A (ja) * 2005-06-30 2009-01-08 ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニーBristol−Myers Squibb Pharma Company イメージング剤としてのヒドラジドコンジュゲート
US7824659B2 (en) 2005-08-10 2010-11-02 Lantheus Medical Imaging, Inc. Methods of making radiolabeled tracers and precursors thereof
US9149545B2 (en) * 2005-11-02 2015-10-06 General Electric Company Nanoparticle-based imaging agents for X-ray/computed tomography and methods for making same
US20070098640A1 (en) * 2005-11-02 2007-05-03 General Electric Company Nanoparticle-based imaging agents for X-ray/computed tomography
EP1991577A2 (en) 2006-01-31 2008-11-19 Parkinson, John F. Modulation of mdl-1 activity for treatment of inflammatory disease
JP5946992B2 (ja) 2008-02-29 2016-07-06 ランセウス メディカル イメージング, インコーポレイテッド 灌流造影を含む適用のための造影剤
EP2296550B1 (en) * 2008-07-07 2018-03-28 Koninklijke Philips N.V. K-edge imaging
US9687571B2 (en) 2009-04-15 2017-06-27 Lantheus Medical Imaging, Inc. Stabilization of radiopharmaceutical compositions using ascorbic acid
WO2011035140A1 (en) 2009-09-18 2011-03-24 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of contrast moieties to the lungs
US8936777B2 (en) 2010-02-08 2015-01-20 Lantheus Medical Imaging, Inc. Methods and apparatus for synthesizing imaging agents, and intermediates thereof
EP2540321A1 (en) 2011-06-30 2013-01-02 Bayer Intellectual Property GmbH Bis Tridentate W3O2 Clusters for X-Ray imaging
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
EP2733148A1 (en) 2012-11-15 2014-05-21 Bayer Pharma Aktiengesellschaft Tungsten complexes with di-dentate ligands
WO2014144708A1 (en) 2013-03-15 2014-09-18 The Regents Of The University Of California Peptides having reduced toxicity that stimulate cholesterol efflux

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US468759A (en) 1892-02-09 Gabeiel a
US3860611A (en) * 1972-01-19 1975-01-14 Du Pont Macrocyclic polyether polyols and condensation polymers derived therefrom
US3763188A (en) * 1972-01-19 1973-10-02 Du Pont Spiro(1,1-polyethylenedi(oxymethyl))-3-oxetanes
US3952015A (en) * 1973-11-12 1976-04-20 Carl George Krespan Macrocyclic compounds having oxa and aza linkages in the ring and containing spirooxetane groups
US4079124A (en) * 1976-04-21 1978-03-14 Medi-Physics, Inc. Method of preparing X-ray contrast media containing ores of hafnium, tantalum and tungsten
US4176173A (en) * 1977-07-18 1979-11-27 Medi-Physics, Inc. Radiographic compositions
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4652519A (en) 1983-02-03 1987-03-24 Yeda Research And Development Company Limited Bifunctional chelating agents and process for their production
US4826673A (en) 1985-01-09 1989-05-02 Mallinckrodt, Inc. Methods and compositions for enhancing magnetic resonance imaging
CA1282069C (en) 1985-09-12 1991-03-26 Damon L. Meyer Antibody complexes of hapten-modified diagnostic or therapeutic agents
US4795698A (en) * 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
IT1213029B (it) 1986-01-30 1989-12-07 Bracco Ind Chimica Spa Chelati di ioni metallici paramagnetici.
WO1989000557A1 (en) 1987-07-16 1989-01-26 Cockbain, Julian, Roderick, Michaelson Aminopolycarboxylic acids and derivatives thereof
FR2630547A1 (fr) * 1988-04-22 1989-10-27 Centre Nat Rech Scient Marquage froid de molecules de nature peptidique ou proteique
AU628403B2 (en) * 1988-09-29 1992-09-17 Access Pharmaceuticals, Inc. Methods and compositions for magnetic resonance imaging
US5260050A (en) * 1988-09-29 1993-11-09 Ranney David F Methods and compositions for magnetic resonance imaging comprising superparamagnetic ferromagnetically coupled chromium complexes
GB9006977D0 (en) * 1990-03-28 1990-05-23 Nycomed As Compositions
US5186923A (en) * 1990-10-10 1993-02-16 Brigham And Womens Hospital Enhancement of cellular accumulation of lipophilic cationic organometallic compounds by reduction of intramembrane potential
EP0597865B1 (en) * 1991-08-05 2001-07-25 Mallinckrodt Inc. Heavy metal clusters for use as imaging agents

Also Published As

Publication number Publication date
GB9006977D0 (en) 1990-05-23
WO1991014460A1 (en) 1991-10-03
EP0521977B1 (en) 1996-09-11
CA2079212A1 (en) 1991-09-29
US5458869A (en) 1995-10-17
ES2091323T3 (es) 1996-11-01
AT142508T (de) 1996-09-15
LV10056A (lv) 1994-05-10
DK0521977T3 (da) 1996-09-30
LT3535B (en) 1995-11-27
JPH06507147A (no) 1994-08-11
EP0645146A1 (en) 1995-03-29
NO923739L (no) 1992-11-06
EP0521977A1 (en) 1993-01-13
LV10056B (en) 1995-02-20
US5614168A (en) 1997-03-25
SG43931A1 (en) 1997-11-14
FI924297A0 (fi) 1992-09-25
FI924297A (fi) 1992-09-25
HK219596A (en) 1997-01-03
AU7557891A (en) 1991-10-21
FI924297D0 (no)
HUT69168A (en) 1995-08-28
AU645796B2 (en) 1994-01-27
HU9203086D0 (en) 1992-12-28
DE69122092D1 (de) 1996-10-17
DE69122092T2 (de) 1997-03-06
LTIP609A (en) 1994-12-27

Similar Documents

Publication Publication Date Title
NO2009021I1 (no) Protein D
NO930189D0 (no) Tioeterkonjugat
NO930489D0 (no) Utsugingskontrollsystem
NO311663B1 (no) Injeksjonspröyte
NO308752B1 (no) Produksjonsnippel
NO930819L (no) Sulfonamidokarboksamider
NO931638D0 (no) Fenylsulfonamid - endothelin - antagonister
NO932695D0 (no) Deoksytaksoler
NO319456B1 (no) Vaeskeinfusjonskrave
NO930302L (no) Reduksjons-prosessor
NO932705D0 (no) Smoereoljer
NO312612B1 (no) Osteosyntesehjelpemiddel
NO913785L (no) Fibrinogenreseptorantagonister
NO931389D0 (no) Haandbeskrivbar lc-tavle
NO932407L (no) Antigastritt-middel
NO930420L (no) Flerstadiumpolymerer
NO920611L (no) Hullaapner
NO930130D0 (no) Kontrastmiddel
NO177364B (no) Kjökkenventilator
NO924797L (no) Kompresjonskjölesystem
NO176069B (no) Rörbolt
NO920115D0 (no) Kortholder
NO934366D0 (no) Konvalent modifiserte mikropartikul{re kontrastmidler
NO180666C (no) Tannbörste
NO304323B1 (no) R°rkobling